Invion Limited (ASX:IVX)

Australia · Delayed Price · Currency is AUD

0.0340

0.00 (0.00%)

Nov 4, 2026, 2:35 PM AEDT

Market Cap	3.71M -50.2%
Revenue (ttm)	384.71K
Net Income	-5.63M
EPS	-0.06
Shares Out	109.20M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,165
Open	0.0370
Previous Close	0.0340
Day's Range	0.0340 - 0.0370
52-Week Range	0.0320 - 0.1100
Beta	0.21
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 25, 2026

About Invion

Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in South Korea. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme (GBM), lung, and ovarian cancers; and human papilloma virus. It is also involved in the development of INV043, which is in Phase II clinical trial for the treatment of patients with prostate cancer; and in Phase I/II ... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2000

Employees 4

Stock Exchange Australian Securities Exchange

Ticker Symbol IVX

Full Company Profile

Financial Performance

Financial Statements